Interleukin-7
Alternative Names: Pre-B-cell growth factor; Pre-BSF-1Latest Information Update: 24 Oct 2021
At a glance
- Originator Amgen
- Developer Amgen; Sanofi Winthrop
- Class Anti-infectives; Antibacterials; Antineoplastics; Antiretrovirals; Antivirals; Cytokines; Interleukins; Recombinant proteins
- Mechanism of Action Interleukin 7 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chemotherapy-induced damage; Diabetes mellitus
Most Recent Events
- 28 Apr 1998 No-Development-Reported for Chemotherapy induced damage/Chemoprotection in USA (Unknown route)
- 17 Apr 1997 No-Development-Reported for Diabetes mellitus in USA (Unknown route)
- 11 Jul 1995 Preclinical development for Chemotherapy induced damage/Chemoprotection in USA (Unknown route)